American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine

Author:

Kattan Michael W.1,Hess Kenneth R.2,Amin Mahul B.3,Lu Ying4,Moons Karl G.M.5,Gershenwald Jeffrey E.6,Gimotty Phyllis A.7,Guinney Justin H.8,Halabi Susan9,Lazar Alexander J.10,Mahar Alyson L.11,Patel Tushar12,Sargent Daniel J.13,Weiser Martin R.14,Compton Carolyn15,

Affiliation:

1. Chairman, Department of Quantitative Health Sciences in the Lerner Research Institute, Cleveland Clinic, Cleveland, OH; Professor of Medicine, Epidemiology, and Biostatistics; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University; Cleveland OH

2. Professor, Department of Biostatistics; The University of Texas MD Anderson Cancer Center; Houston TX

3. Professor and Chair Emeritus, Department of Pathology and Laboratory Medicine; Cedars-Sinai Medical Center; Los Angeles CA

4. Professor of Biomedical Data Science (Statistics), Department of Biomedical Data Science and Department of Health Research and Policy; Stanford University; Stanford, CA; Director, US VA Cooperative Studies Program, Palo Alto CA

5. Professor of Clinical Epidemiology, Julius Center for Health Sciences and Primary Care; UMC Utrecht; Utrecht The Netherlands

6. Dr. John M. Skibber Professor, Department of Surgical Oncology, and Professor, Department of Cancer Biology; The University of Texas MD Anderson Cancer Center; Houston TX

7. Professor of Biostatistics, Department of Biostatistics and Epidemiology; University of Pennsylvania Perelman School of Medicine; Philadelphia PA

8. Director of Computational Oncology; Sage Bionetworks; Seattle WA

9. Professor, Department of Biostatistics and Bioinformatics; Duke University; Durham NC

10. Associate Professor, Department of Pathology; The University of Texas MD Anderson Cancer Center; Houston TX

11. PhD Candidate, Department of Public Health Sciences; Queen's University; Kingston Ontario Canada

12. Assistant Professor, Department of Pathology; University of Illinois Hospital and Health Sciences System; Chicago IL

13. Professor of Biostatistics and Oncology, Division of Biomedical Statistics and Informatics; Mayo Clinic; Rochester MN

14. Attending Surgeon, Department of Surgery; Memorial Sloan Kettering Cancer Center, New York, NY; Professor of Surgery, Weill Cornell Medical College; New York NY

15. Professor, Life Science; Arizona State University, Tempe, AZ; Professor, Laboratory Medicine and Pathology, Mayo Clinic School of Medicine, Rochester, MN; Chief Medical Officer, National Biomarker Development Alliance, Scottsdale; AZ

Publisher

Wiley

Subject

Oncology,Hematology

Reference10 articles.

1. History and international developments in cancer staging;Gospodarowicz;Cancer Prev Control.,1998

2. Improving the quality of cancer staging;Asare;CA Cancer J Clin.,2015

3. 2010 TNM staging system for cutaneous melanoma…and beyond;Gershenwald;Ann Surg Oncol.,2010

4. Translating clinical research into clinical practice: impact of using prediction rules to make decisions;Reilly;Ann Intern Med.,2006

5. Assessing the generalizability of prognostic information;Justice;Ann Intern Med.,1999

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3